CN106565521B — (s)-2-[3-(3-氟苄基)-4-(3-氟苄氧基)苄氨基]丙酰胺及其盐的制备方法
Assigned to Zhejiang Menovo Pharmaceutical Co Ltd · Expires 2019-03-08 · 7y expired
What this patent protects
本发明涉及一种(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺及其盐的制备方法，其中，(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺的盐是指(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺甲磺酸盐，该制备方法通过合成新的化合物2‑(3‑溴‑4‑((3‑氟苄基)氧基)苯基)‑1,3‑二氧戊环与化合物2‑((3‑氟苄基)氧基)‑5‑甲酰基苯硼酸进行目标产物的制备，属于全新的制备方法，且该制备方法所制备(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺收率为49.57％，HPLC纯…
USPTO Abstract
本发明涉及一种(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺及其盐的制备方法，其中，(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺的盐是指(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺甲磺酸盐，该制备方法通过合成新的化合物2‑(3‑溴‑4‑((3‑氟苄基)氧基)苯基)‑1,3‑二氧戊环与化合物2‑((3‑氟苄基)氧基)‑5‑甲酰基苯硼酸进行目标产物的制备，属于全新的制备方法，且该制备方法所制备(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺收率为49.57％，HPLC纯度达到78.92％，所制备(S)‑2‑[3‑(3‑氟苄基)‑4‑(3‑氟苄氧基)苄氨基]丙酰胺的盐收率为50.40％，HPLC纯度达到96.35％，较现有技术获得极大提高。
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.